- Home
- ASTS vs NBIX Comparison
ASTS vs NBIX Comparison
Compare ASTS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTS | NBIX |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 14.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ASTS | NBIX |
|---|---|---|
| Price | $74.03 | $155.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $59.37 | ★ $173.79 |
| AVG Volume (30 Days) | ★ 10.6M | 969.9K |
| Earning Date | 11-10-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | N/A | ★ 4.19 |
| Revenue | $18,531,000.00 | ★ $2,682,700,000.00 |
| Revenue This Year | $1,223.27 | $23.76 |
| Revenue Next Year | $363.99 | $18.01 |
| P/E Ratio | ★ N/A | $37.10 |
| Revenue Growth | ★ 641.24 | 19.61 |
| 52 Week Low | $17.50 | $84.23 |
| 52 Week High | $102.79 | $157.67 |
Technical Indicators
Market Signals| Indicator | ASTS | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 64.81 |
| Support Level | $52.20 | $150.26 |
| Resistance Level | $57.81 | $154.35 |
| Average True Range (ATR) | 5.09 | 4.16 |
| MACD | 2.14 | 1.07 |
| Stochastic Oscillator | 95.81 | 93.25 |
Price Performance
Historical ComparisonAbout ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.